Nextage Therapeutics Ltd (NXTG.TA)

ILA 104.5

(0.97%)

Operating Income Summary of Nextage Therapeutics Ltd

  • Nextage Therapeutics Ltd's latest annual operating income in 2023 was -3.98 Million ILS , up 31.79% from previous year.
  • Nextage Therapeutics Ltd's latest quarterly operating income in 2023 FY was -3.98 Million ILS , up 31.79% from previous quarter.
  • Nextage Therapeutics Ltd reported an annual operating income of -5.84 Million ILS in 2022, up 23.87% from previous year.
  • Nextage Therapeutics Ltd reported an annual operating income of -7.67 Million ILS in 2021, up 51.35% from previous year.
  • Nextage Therapeutics Ltd reported a quarterly operating income of -2.26 Million ILA for 2023 Q2, up 21.15% from previous quarter.
  • Nextage Therapeutics Ltd reported a quarterly operating income of -1.72 Million ILA for 2023 Q4, up 23.82% from previous quarter.

Annual Operating Income Chart of Nextage Therapeutics Ltd (2023 - 2016)

Historical Annual Operating Income of Nextage Therapeutics Ltd (2023 - 2016)

Year Operating Income Operating Income Growth
2023 -3.98 Million ILS 31.79%
2022 -5.84 Million ILS 23.87%
2021 -7.67 Million ILS 51.35%
2020 -15.78 Million ILS -258.33%
2019 -4.4 Million ILS 56.18%
2018 -10.05 Million ILS -51.9%
2017 -6.61 Million ILS 7.48%
2016 -7.15 Million ILS 0.0%

Peer Operating Income Comparison of Nextage Therapeutics Ltd

Name Operating Income Operating Income Difference
Cannabotech LTD -16.62 Million ILA 76.018%